Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T00:47:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T18:42:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision updates from v3.7.1 to v3.7.2.
    Difference
    0.6%
    Check dated 2026-10-20T20:18:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1, reflecting an updated website release version.
    Difference
    0.1%
    Check dated 2026-10-06T20:39:36.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The history now shows a new revision tag upgrading from v3.6.6 to v3.7.0, representing a new version entry for the study record history.
    Difference
    0.1%
    Check dated 2026-09-15T20:32:16.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 is added to the history and the previous Revision: v3.6.5 is removed. This reflects a minor platform/UI update to the record history display rather than any change to the study data.
    Difference
    0.1%
    Check dated 2026-09-01T19:40:43.000Z thumbnail image

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.